Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy

• Roy Fleischmann,
• Yuko Kaneko,
• Rieke Alten,
• Chad Walls,
• Natalia Bello,
• Peter C. Taylor,
• Jorge Ross Terres,
• Jose María Álvaro Gracia,
• Amanda Quebe,
• Bochao Jia

Affiliations

Roy Fleischmann

Metroplex Clinical Research Center, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA

Yuko Kaneko

Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Minato-ku, Tokyo, Japan

Rieke Alten

Internal Medicine II, Rheumatology, Schlosspark-Klinik, University Medicine Berlin, Berlin, Germany

Chad Walls

Eli Lilly and Co, Indianapolis, Indiana, USA

Natalia Bello

Eli Lilly and Company, Indianapolis, Indiana, USA

Peter C. Taylor

Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK

Jorge Ross Terres

Eli Lilly and Company, Indianapolis, Indiana, USA

Jose María Álvaro Gracia

Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

Amanda Quebe

Eli Lilly and Company, Indianapolis, Indiana, USA

Bochao Jia

Eli Lilly and Company, Indianapolis, Indiana, USA